PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
XLVS.L vs. BTEE.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

XLVS.L vs. BTEE.L

Last updated Apr 2, 2026

Compare and contrast key facts about Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L).

XLVS.L and BTEE.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XLVS.L is a passively managed fund by Invesco that tracks the performance of the S&P® Select Sector Capped 20% Health Care Index. It was launched on Dec 16, 2009. BTEE.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Mar 5, 2018. Both XLVS.L and BTEE.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

XLVS.L vs. BTEE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

XLVS.L vs. BTEE.L - Yearly Performance Comparison

2026 (YTD)20252024202320222021202020192018
XLVS.L
Invesco Health Care S&P US Select Sector UCITS ETF Acc		-4.71%14.78%2.15%1.56%-2.62%27.57%12.04%20.54%2.23%
BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)		3.29%32.82%-1.69%5.84%-11.88%-0.57%27.55%25.56%-14.84%

Returns By Period

In the year-to-date period, XLVS.L achieves a -4.71% return, which is significantly lower than BTEE.L's 3.29% return.

XLVS.L

1D
1.78%
1M
-6.39%
YTD
-4.71%
6M
4.80%
1Y
3.47%
3Y*
6.07%
5Y*
6.19%
10Y*
9.53%

BTEE.L

1D
2.25%
1M
-1.36%
YTD
3.29%
6M
17.25%
1Y
39.34%
3Y*
13.16%
5Y*
4.62%
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Invesco Health Care S&P US Select Sector UCITS ETF Acc

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

Often compared with XLVS.L:
XLVS.L vs. XLVP.LXLVS.L vs. IUHC.LXLVS.L vs. GLDXLVS.L vs. CSPX.LXLVS.L vs. IGLN.LXLVS.L vs. XDEV.DEXLVS.L vs. IHYA.L
Often compared with BTEE.L:
BTEE.L vs. VOOBTEE.L vs. NBTK.DEBTEE.L vs. DOCT.LBTEE.L vs. WHCE.LBTEE.L vs. GNOG.LBTEE.L vs. WBIO.LBTEE.L vs. BIGT.L

XLVS.L vs. BTEE.L - Expense Ratio Comparison

XLVS.L has a 0.14% expense ratio, which is lower than BTEE.L's 0.35% expense ratio.

BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
XLVS.L
Invesco Health Care S&P US Select Sector UCITS ETF Acc

Return for Risk

XLVS.L vs. BTEE.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
XLVS.L
XLVS.L Risk / Return Rank: 1717
Overall Rank
XLVS.L Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
XLVS.L Sortino Ratio Rank: 1616
Sortino Ratio Rank
XLVS.L Omega Ratio Rank: 1616
Omega Ratio Rank
XLVS.L Calmar Ratio Rank: 1919
Calmar Ratio Rank
XLVS.L Martin Ratio Rank: 1717
Martin Ratio Rank
BTEE.L
BTEE.L Risk / Return Rank: 8686
Overall Rank
BTEE.L Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
BTEE.L Sortino Ratio Rank: 8585
Sortino Ratio Rank
BTEE.L Omega Ratio Rank: 7777
Omega Ratio Rank
BTEE.L Calmar Ratio Rank: 8989
Calmar Ratio Rank
BTEE.L Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XLVS.L vs. BTEE.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

XLVS.LBTEE.LDifference

Sharpe ratio

Return per unit of total volatility

0.20

1.77

-1.57

Sortino ratio

Return per unit of downside risk

0.40

2.38

-1.98

Omega ratio

Gain probability vs. loss probability

1.05

1.31

-0.26

Calmar ratio

Return relative to maximum drawdown

0.39

3.20

-2.81

Martin ratio

Return relative to average drawdown

0.83

14.39

-13.56

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XLVS.L vs. BTEE.L - Sharpe Ratio Comparison

The current XLVS.L Sharpe Ratio is 0.20, which is lower than the BTEE.L Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of XLVS.L and BTEE.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

XLVS.LBTEE.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.20

1.77

-1.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.43

0.22

+0.21

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.62

—

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.63

0.30

+0.33

Correlation

The correlation between XLVS.L and BTEE.L is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

XLVS.L vs. BTEE.L - Dividend Comparison

XLVS.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.36%.

TTM20252024202320222021202020192018
XLVS.L
Invesco Health Care S&P US Select Sector UCITS ETF Acc		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BTEE.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)		0.36%0.37%0.46%0.39%0.44%0.25%0.17%0.14%0.07%

Drawdowns

XLVS.L vs. BTEE.L - Drawdown Comparison

The maximum XLVS.L drawdown since its inception was -26.88%, smaller than the maximum BTEE.L drawdown of -38.29%. Use the drawdown chart below to compare losses from any high point for XLVS.L and BTEE.L.

Loading graphics...

Drawdown Indicators

XLVS.LBTEE.LDifference

Max Drawdown

Largest peak-to-trough decline

-26.88%

-38.29%

+11.41%

Max Drawdown (1Y)

Largest decline over 1 year

-10.69%

-14.02%

+3.33%

Max Drawdown (5Y)

Largest decline over 5 years

-17.56%

-38.29%

+20.73%

Max Drawdown (10Y)

Largest decline over 10 years

-26.88%

—

—

Current Drawdown

Current decline from peak

-7.16%

-2.70%

-4.46%

Average Drawdown

Average peak-to-trough decline

-4.85%

-13.78%

+8.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.95%

2.81%

+2.14%

Volatility

XLVS.L vs. BTEE.L - Volatility Comparison

The current volatility for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) is 4.65%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a volatility of 7.46%. This indicates that XLVS.L experiences smaller price fluctuations and is considered to be less risky than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

XLVS.LBTEE.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.65%

7.46%

-2.81%

Volatility (6M)

Calculated over the trailing 6-month period

9.65%

14.21%

-4.56%

Volatility (1Y)

Calculated over the trailing 1-year period

17.31%

22.17%

-4.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.54%

21.18%

-6.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.44%

22.50%

-7.06%